[对直肠癌的新辅助治疗后完整反应的评估策略]
1Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Zhonghua wai ke za zhi [Chinese journal of surgery]
|July 25, 2023
概括
目前用于直肠癌的临床完整反应 (cCR) 的标准缺乏病理确认. 经过透活检的修改cCR (m-cCR) 可以提高观察和等待策略的准确性和安全性.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 医疗成像医学成像
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
506
